ISSN: 2475-7640

Zeitschrift für klinische und experimentelle Transplantation

Offener Zugang

Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Abstrakt

Transplantation Transformation: Harnessing Cellular Therapies

Wang G

The field of transplantation medicine has witnessed remarkable advancements in recent years, driven by the emergence of cellular therapies. This abstract provides an overview of the transformative potential of cellular therapies in the context of transplantation. Cellular therapies represent a paradigm shift in the management of organ transplantation, offering a promising alternative to traditional transplantation methods. This abstract highlights key aspects of cellular therapies, including their mechanisms of action, applications, and potential benefits. First, the abstract discusses the fundamental principles underlying cellular therapies. These therapies involve the isolation, expansion, and manipulation of specific cell types, such as mesenchymal stem cells, regulatory T cells, and induced pluripotent stem cells. These cells can be utilized to modulate the immune system, repair damaged tissues, and induce transplant tolerance. Next, the abstract explores the diverse applications of cellular therapies in transplantation. From enhancing graft survival to reducing the reliance on immunosuppressive drugs, cellular therapies offer a versatile toolkit for transplant clinicians. Moreover, they hold promise for regenerative medicine approaches, allowing the repair and regeneration of injured or degenerated organs. Furthermore, this abstract delves into the potential benefits of cellular therapies. By reducing graft rejection rates, minimizing complications, and improving long-term outcomes, cellular therapies have the potential to revolutionize transplantation outcomes. Additionally, the mitigation of transplant-related morbidities and the prospect of personalized medicine approaches contribute to the allure of cellular therapies.